Zolmitriptan Orally Disintegrating Tablet in Primary Care Migraine Therapy: Patient- and Physician-reported Outcomes from a Patient Treatment Experience Study

Author： Shapero Gary   Dowson Andrew   Lacoste Jean-Pierre   Almqvist Per  

Publisher： Informa Healthcare

ISSN： 1742-3430

Source： Headache Care, Vol.2, Iss.4, 2005-12, pp. : 257-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zolmitriptan Orally Disintegrating Tablet (ODT) is a Highly Effective Migraine Therapy that Patients Prefer Over Other Commonly Used Treatments

By Dowson Andrew   Charlesworth Bruce  

Headache Care, Vol. 1, Iss. 1, 2004-03 ,pp. : 78-80

Informa Healthcare

Access to resources Recommend Favorite

Physician-reported treatment outcomes for ADHD among children and adolescents in Europe

By Setyawan Juliana   Fridman Moshe   Hodgkins Paul   Quintero Javier   Erder M Haim   Katić Božena   Harpin Valerie  

Neuropsychiatry, Vol. 3, Iss. 6, 2013-12 ,pp. : 587-600

Future Medicine

Access to resources Recommend Favorite

Evaluation of a Comprehensive Physician and Patient Education Programme for the Treatment of Migraine: Interim Results from the Mercy Migraine Management Project

By Smith Timothy R.  

Headache Care, Vol. 1, Iss. 3, 2004-08 ,pp. : 195-198

Informa Healthcare

Access to resources Recommend Favorite

Migraine Patients Prefer Zolmitriptan Orally Disintegrating Tablets (ODT) to Eletriptan Oral Tablets

By Shimizu Toshihiko   Iwata Makoto  

Headache Care, Vol. 1, Iss. 4, 2004-12 ,pp. : 299-301

Informa Healthcare

Access to resources Recommend Favorite

Zolmitriptan Nasal Spray Improves Patient Satisfaction by Providing Fast and Effective Relief from Migraine Symptoms

By Dahlöf Carl   Boes-Hansen Steen   Dowson Andrew  

Headache Care, Vol. 1, Iss. 1, 2004-03 ,pp. : 85-94

Informa Healthcare

Access to resources Recommend Favorite